PlainPharmaWatch

CMS Open Payments · Program Year 2024

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. reported $421,191.53 in payments to 810 physicians and teaching hospitals across 810 transactions.

See the rankings → How this is sourced
$421.2K
Total payments
810
Transactions
810
Recipients
−$377.6K
General Payments vs PY2023

Bio-Rad Laboratories, Inc. reported $421,191.53 in payments to 810 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #806 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $519.99 per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Bio-Rad Laboratories, Inc. pairs above-median payment volume with a broadly spread payment pattern across many recipients.

#806
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
4
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Bio-Rad Laboratories, Inc.'s CMS-reported General Payments decreased by $377.6K (−47.3%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: BIO-RAD LABORATORIES, INC.PY2023: BIO-RAD LABORATORIES, INC.PY2024: Bio-Rad Laboratories, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$798.8KPY2024$421.2K
PY2023
$798,824.97
PY2024
$421,191.53

How Bio-Rad Laboratories, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Bio-Rad Laboratories, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$421,192 Top 42% higher than 58% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). This entry sits in this band. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Bio-Rad Laboratories, Inc.

Averaging $519.99 per transaction and $519.99 per recipient, Bio-Rad Laboratories, Inc.'s Program Year 2024 total comes to $421,191.53 across 810 transactions and 810 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #806 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 4 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $393.2K across 591 transactions, 93.3% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 4 types of general payments, Bio-Rad Laboratories, Inc.'s largest category was "Compensation for Services Other Than Consulting" at $393.2K - 93.3% of the company's reported total.

How Bio-Rad Laboratories, Inc. divides its payments

Ranked by total dollars reported per category

1. Compensation for Services…$393.2K2. Long-Term Medical Supply …$21.9K3. Debt Forgiveness$5.7K4. Food and Beverage$439.53
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $393.2K 591
Long-Term Medical Supply or Device Loan $21.9K 21
Debt Forgiveness $5.7K 194
Food and Beverage $439.53 4

Recipient Concentration in General Payments

The five largest recipient relationships account for $190,523.28 (45.2%) of $421,191.53 in this company's General Payments records across 77 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Bio-Rad Laboratories, Inc.

The five named recipients with the highest reported General Payments from this company

Wakemed Raleigh Campus$54.3KPresence St. Joseph Medical …$43.9KCook Childrens Medical Center$40.6KHartford Hospital$26.1KUt Md Anderson Cancer Center$25.7K
  1. 1

    Wakemed Raleigh Campus

    $54,280.00 across 61 reported transactions

  2. 2

    Presence St. Joseph Medical Center

    $43,928.01 across 62 reported transactions

  3. 3

    Cook Childrens Medical Center

    $40,560.00 across 59 reported transactions

  4. 4

    Hartford Hospital

    $26,067.91 across 57 reported transactions

  5. 5

    Ut Md Anderson Cancer Center

    $25,687.36 across 13 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $519.99. Average per recipient: $519.99.

Total Amount

$421,191.53

Avg per Transaction

$519.99

Avg per Recipient

$519.99

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Bio-Rad Laboratories, Inc. Share

0.0%

#806 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Bio-Rad Laboratories, Inc.

Rayner Intraocular Lenses Limited

$421.7K 2,145 recipients

Almatica Pharma LLC

$421.9K 15,812 recipients

CeQur Corporation

$420.1K 9,797 recipients

Cepheid

$423.4K 260 recipients

WyCo Surgical Distribution LLC

$418.5K 0 recipients

Incline Medical

$417.4K 0 recipients

Frequently Asked Questions

How much did Bio-Rad Laboratories, Inc. pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $421,191.53 from Bio-Rad Laboratories, Inc. to physicians and hospitals across 810 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Bio-Rad Laboratories, Inc.? ▾
Bio-Rad Laboratories, Inc. made payments to 810 physicians and teaching hospitals in 2024. The average payment per recipient was $519.99.
What types of payments did Bio-Rad Laboratories, Inc. make? ▾
Bio-Rad Laboratories, Inc. made 4 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Compensation for Services Other Than Consulting" at $393.2K, representing 93.3% of the company's reported total.
How does Bio-Rad Laboratories, Inc. rank among pharmaceutical companies? ▾
By total payment amount, Bio-Rad Laboratories, Inc. sits at #806 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Bio-Rad Laboratories, Inc.? ▾
Bio-Rad Laboratories, Inc.'s 810 transactions to 810 recipients in 2024 averaged $519.99 per transaction.
Where does the payment data for Bio-Rad Laboratories, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Bio-Rad Laboratories, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.